---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-344748"
form_type: "8-K"
ticker: "SEER"
cik: "0001726445"
company_name: "Seer, Inc."
filed_at: "2026-08-11T20:23:00+00:00"
generated_at: "2026-08-11T20:24:06.181381+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Seer Q2 2026 revenue down 23% to $3.1M; net loss $16.9M; reaffirms FY26 guidance

## Summary
- Revenue $3.1M vs $4.1M in Q2 2025, a 23% decline on macro headwinds and longer sales cycles.
- Net loss narrowed to $16.9M from $19.4M; operating expenses fell 19% to $18.3M.
- Cash, equivalents and investments ~$209.5M at June 30, 2026; repurchased ~200,000 shares.
- Reaffirms FY2026 revenue guidance of $16M-$18M, implying ~3% growth at midpoint.
- Initiated ITC investigation against Nanomics for alleged patent infringement on Proteograph.

## SEC filing metadata
- accession: 0001193125-26-344748
- form_type: 8-K
- ticker: SEER
- cik: 0001726445
- company_name: Seer, Inc.
- filed_at: 2026-08-11T20:23:00+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726445/000119312526344748/0001193125-26-344748-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726445/000119312526344748/ck0001726445-20260811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-344748
- JSON: https://secwatch.observer/filing/0001193125-26-344748.json
- Plain text: https://secwatch.observer/filing/0001193125-26-344748.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.